Aspergillus fumigatus mitral native valve endocarditis

Journal of Heart Valve Disease

Volumn 18, Issue 4, 2009, Pages 472-473

  Fayad, G ^a   Legout, L ^b   Colombie, V ^b   Modine, T ^a   Senneville, E ^b   Leroy, O ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Service Universitaire des Maladies Infectieuses et du Voyageur   (France)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; ENDOCARDITIS; HUMAN; LETTER; MALE; MICROBIOLOGY; MIDDLE AGED; MITRAL VALVE;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ENDOCARDITIS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE;

EID: 79957701650     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: Evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32:50-62
2. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122:302-310
3. Herbrecht R, Denning DW, Patterson TF, et al., for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-415
4. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004; 39:797-802